8 completed, 8 not yet recruiting, 3 recruiting, 2 unknown. 8 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 4, 1 Phase 1.
Follow Insulin Resistance Syndrome: new trials by email Literature Review of Insulin Resistance Syndrome trials Research Report on Insulin Resistance Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alpha-Lipoic Acid Added to Dapagliflozin and Insulin Resistance in Type 2 Diabetes Alpha-Lipoic Acid (ALA), Placebo - Diabetes Mellitus, Type 2, Insulin Resistance Syndrome | Phase 3 | Not yet recruiting | Fayoum University | 70 | 2026-12-01 | 2026-11-12 |
| Precision Exercise Using Myostatin/Follistatin Ratio in Obese Adults Supervised Progressive Resistance Training, Standard Lifestyle Advice - Sarcopenic Obesity, Obesity & Overweight | Not applicable | Not yet recruiting | Diabetes Foundation, India | 200 | 2026-12-01 | 2026-11-19 |
| Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) Extended Serum Biomarker and Hormonal Panel, Liver Elastography with Controlled Attenuation Parameter, Targeted Genotyping of PNPLA3 rs738409 and HSD17B13 rs72613567 - Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease | Not yet recruiting | Kayseri City Hospital | 150 | 2026-09-01 | 2026-07-30 | |
| Non-Invasive Diagnostic Panel for MASLD in Children With Obesity Non-Invasive Multi-Parameter Diagnostic Panel - Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity | Not yet recruiting | Kayseri City Hospital | 180 | 2026-07-01 | 2026-07-30 | |
| Cf-PWV and TyG Index Study Hypertension, Insulin Resistance Syndrome | Not yet recruiting | Hospital de Base | 800 | 2026-07-01 | 2026-05-22 | |
| SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level Pleasant Food Odor Stimulation, Control Environmental Condition - Obesity & Overweight, Insulin Resistance Syndrome | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 20 | 2026-06-01 | 2026-06-10 |
| CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry Tirzepatide - Psoriatic Arthritis, Osteoarthitis | Not yet recruiting | JULIO GRANADOS MONTIEL | 30 | 2026-05-01 | 2026-05-12 | |
| Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention. Artichoke by-product capsules, Energy-restricted Mediterranean diet (erMeDiet), Placebo capsules - Diabete Type 2, Obesity & Overweight | Not applicable | Recruiting | Clinica Universidad de Navarra, Universidad de Navarra | 150 | 2026-05-01 | 2026-04-29 |
| Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli No Intervention: Observational Cohort - Insulin Resistance Syndrome, Cardio Vascular Disease | Completed | Comune di Napoli | 123752 | 2026-01-25 | 2026-08-25 | |
| ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic Syndrome | Not yet recruiting | Jarosław Drobnik | 10000 | 2026-01-05 | 2026-01-15 | |
| Gummy Candies With Maqui Berry GM, Control, GMM - Overweight (BMI > 25), Obesity & Overweight | Not applicable | Completed | Gonzalo Jorquera, PhD | 10 | 2025-12-02 | 2026-01-28 |
| Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study No intervention (observational study) - Polycystic Ovary Syndrome (PCOS), Insulin Resistance Syndrome | Enrolling by invitation | Havva Betül Bacak | 128 | 2025-06-18 | 2025-08-06 | |
| Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause Hyperbaric oxygen therapy, Hypoglycemic Drug - Insulin Resistance Syndrome | Phase 1 / Phase 2 | Recruiting | Cairo University | 40 | 2025-01-28 | 2025-02-04 |
| Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults Step counts for predictable changes in body weight/compositon and cardiometabolic risk - Dyslipidemia, Insulin Resistance Syndrome | Not applicable | Recruiting | Kennesaw State University | 200 | 2025-01-13 | 2025-10-27 |
| Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults Glycine - Older Adults With Cognitive Decline, Insulin Resistance Syndrome | Not applicable | Completed | Brenda Sarahí Beristain Lujano | 59 | 2024-12-01 | 2026-06-15 |
| Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan Metformin - Polycystic Ovary Syndrome (PCOS) Women, Insulin Resistance Syndrome | Phase 4 | Completed | Jerash Private University | 25 | 2023-06-01 | 2026-08-12 |
| Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance Dosage of IRAP during OGTT - Insulin Resistance Syndrome | Not applicable | Terminated | University Hospital, Grenoble | 21 | 2020-09-14 | 2022-08-11 |
| A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 ) Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B | Phase 3 | Unknown | Kobe University | 8 | 2020-02-01 | 2021-06-03 |
| Causal Mechanisms in Adolescent Arterial Stiffness CS+, CS- - Lipid Disorder, Dyslipidemias | Phase 2 | Completed | Baylor College of Medicine | 72 | 2020-02-01 | 2026-11-02 |
| A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B | Phase 3 | Unknown | Kobe University | 8 | 2019-09-01 | 2021-03-03 |
Showing 20 of 23. Sign in to see all of them.
Metabolic Syndrome (23) · Insulin Resistance (10) · Obesity (7) · Overweight (6) · Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (3) · Pediatric Obesity (3) · Polycystic Ovary Syndrome (3) · Coronary Artery Disease (2) · Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans (2) · Diabetes Mellitus, Lipoatrophic (2) · Dyslipidemias (2) · Fatty Liver (2) · Hypertension (2) · Non-alcoholic Fatty Liver Disease (2)
Glucose Metabolism Disorders (23) · Metabolic Diseases (23) · Nutritional and Metabolic Diseases (23) · Hyperinsulinism (22) · Insulin Resistance (13) · Pathological Conditions, Signs and Symptoms (11) · Body Weight (10) · Nutrition Disorders (10) · Overnutrition (10) · Signs and Symptoms (10) · Endocrine System Diseases (9) · Cardiovascular Diseases (4) · Overweight (4) · Vascular Diseases (4) · Adnexal Diseases (3)
Exercise (2) · Hypoglycemic Agents (2) · empagliflozin (2) · (1-6)-alpha-glucomannan (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Aspirin (1) · Bisoprolol (1) · Dietary Fiber (1) · Glycine (1) · Hyperbaric Oxygenation (1) · Hypolipidemic Agents (1) · Isosorbide Dinitrate (1) · Metformin (1) · Observation (1)
Cairo University (2) · Kayseri City Hospital (2) · Kobe University (2) · Baylor College of Medicine (1) · Brenda Sarahí Beristain Lujano (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · Comune di Napoli (1) · Diabetes Foundation, India (1) · Fayoum University (1) · Gonzalo Jorquera, PhD (1) · Havva Betül Bacak (1) · Hospices Civils de Lyon (1) · Hospital de Base (1) · JULIO GRANADOS MONTIEL (1) · Jarosław Drobnik (1)
Egypt (3) · Turkey (Türkiye) (3) · France (2) · Japan (2) · Mexico (2) · United States (2) · Brazil (1) · Chile (1) · India (1) · Italy (1) · Jordan (1) · Poland (1) · Spain (1) · Ukraine (1)
Wataru Ogawa (2) · Andres Moron, PhD (1) · Iziar Ludwig, PhD (1) · Julio Granados-Montiel, MD, PhD (1) · Justin P Zachariah, MD MPH (1) · Marwin Gutierrez, MD (1) · Professor Anoop Misra, MD (1) · Robert Buresh, PhD (1) · Sherif T Ahmed, teaching assistant (1)
PMID 18820647, PMID 26511519, PMID 37364790, PMID 12493255, PMID 12642361, PMID 14698999, PMID 15741351, PMID 16775236, PMID 18064739, PMID 18511656, PMID 18852641, PMID 19067533, PMID 19268270, PMID 19585618, PMID 20338492, PMID 20624171, PMID 20808246, PMID 20888433, PMID 20937968, PMID 21274322, PMID 22048570, PMID 22157565, PMID 22278144, PMID 22916099, PMID 23519954, PMID 23592667, PMID 23840612, PMID 24029863, PMID 24886823, PMID 25156170, PMID 25199852, PMID 25333031, PMID 26160955, PMID 26512983, PMID 27660603, PMID 27901631, PMID 28107283, PMID 28701474, PMID 29562163, PMID 29872338, PMID 30170852, PMID 30267166, PMID 30827125, PMID 31002414, PMID 31030201, PMID 31255652, PMID 31381969, PMID 31466622, PMID 32008430, PMID 32020770
R01HL148217 (1)